The 5-HT(1A) receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT(1A) receptors

Pharmacology Biochemistry and Behavior

Volumn 57, Issue 1-2, 1997, Pages 301-307

  Allen, Angela R ^a   Singh, Ashish ^a   Zhuang, Zhi Ping ^a   Kung, Mei Ping ^a   Kung, Hank F ^a   Lucki, Irwin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

5 HT syndrome; 8 OH DPAT; Hypothermia; Microdialysis; p MPPI; Serotonin

Indexed keywords

2 DIBUTYLAMINO 8 HYDROXYTETRALIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; RESERPINE; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 (2' METHOXYPHENYL) 1 (2' (N (2'' PYRIDINYL) 4 IODOBENZAMIDO)ETHYL)PIPERAZINE; 4-(2'-METHOXYPHENYL)-1-(2'-(N-(2''-PYRIDINYL)-4-IODOBENZAMIDO)ETHYL)PIPERAZINE; AMINOPYRIDINE DERIVATIVE; PIPERAZINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

AFFECTIVE NEUROSIS; ANIMAL EXPERIMENT; ANXIETY NEUROSIS; ARTICLE; BODY TEMPERATURE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG ANTAGONISM; HYPOTHERMIA; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN SYNDROME; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECT; METABOLISM; SPRAGUE DAWLEY RAT; SYNAPTOSOME; THERMOREGULATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AMINOPYRIDINES; ANIMALS; BEHAVIOR, ANIMAL; BODY TEMPERATURE REGULATION; CORPUS STRIATUM; MALE; MICRODIALYSIS; PIPERAZINES; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0030610708     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00339-5     Document Type: Article

References (48)

1. Barrett, J. E.; Vanover, K. E. 5-HT receptors as targets of the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacology 112:1-12; 1993.
2. Bill, D. J.; Knight, M.; Forster, E. A.; Fletcher, A. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. Br. J. Pharmacol. 103:1857-1864; 1991.
3. 1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: Inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects. J. Pharmacol. Exp. Ther. 258:58-65; 1991.
4. Bonvento, G.; Scatton, B.; Claustre, Y.; Rouquier, L. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neurosci. Lett. 137:101-104; 1992.
5. 1A agonists. Synapse 14:297-304; 1993.
6. 1A receptors. Eur. J. Pharmacol. 237:283-291; 1993.
7. 1A receptor antagonist. Br. J. Pharmacol. 112:91P; 1994.
8. 1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol. Sci. 14:441-448; 1993.
9. Frazer, A.; Maayani, S.; Wolfe, B. B. Subtypes of receptors for serotonin. Ann. Rev. Pharmacol. Toxicol. 30:307-348; 1990.
10. 1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur. J. Pharmacol. 154:339-341; 1988.
11. Goodwin, G. M.; DeSouza, R. J.; Green A. R. The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioral effects of 5-HT agonists in mice and rats. Psychopharmacology 89:382-387; 1986.
12. Hjorth, S. Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT. J. Neural Transm. 61:131-135; 1985.
13. Hjorth, S.; Carlsson, A. Buspirone: Effects on central monoaminergic transmission - possible relevance to animal experimental and clinical findings. Eur. J. Pharmacol. 83:299-303; 1982.
14. 1A receptors: Behavioural and in vivo brain microdialysis studies. Life Sci. 46:955-963; 1990.
15. Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Hartig, P. R.; Martin, G. R.; Mylecharane, E. J.; Saxena, P. R.; Humphrey, P. P. International Union of Pharmacology classification of receptors for 5-hydroxy-tryptamine (Serotonin). Pharmacol. Rev. 46:157-203; 1994.
16. Jacobs B. L. An animal behavior model for studying central serotonergic synapses. Life Sci. 19:777-786; 1976.
17. 1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther. 269:1268-1279; 1994.
18. 1A receptor antagonist: p-MPPI. Life Sci. 55:1459-1462; 1994.
19. 1A sites in rat brain: In vitro binding and autoradiographic studies. J. Pharmacol. Exp. Ther. 272:429-437; 1995.
20. 1 receptors and behavior. Neurosci. Biobehav. Rev. 16:83-93; 1992.
21. Lucki, I.; Nobler, M. S.; Frazer, A. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J. Pharmacol. Exp. Ther. 228:133-139; 1984.
22. Lucki, I.; Singh, A.; Kreiss, D. S. Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci. Biobehav. Rev. 18:85-95; 1994.
23. 1A receptors and behavioral responses. Neuropsychopharmacology 3:481-493; 1990.
24. 1A agonist-like effects of NAN-190. Soc. Neurosci. Abstr. 16:1034; 1990.
25. 1A agonists. Mol. Pharmacol. 37:231-237; 1990.
26. 1 recognition site. Eur. J. Pharmacol. 90:151-153; 1983.
27. 1A antagonists WAY 100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus. Neuropharmacology 33:61-66; 1994.
28. Paxinos, G.; Watson, C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press; 1987.
29. 1 receptors. Brain Res. 346:205-230; 1985.
30. 3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J. Neurochem. 36:220-226; 1981.
31. 1A receptors. Biol. Psychiat. 20:971-979; 1985.
32. Rickels, K.; Amsterdam, J. D.; Clary, C.; Puzzuoli, G.; Schweizer, E. Buspirone in major depression: A controlled study. J. Clin. Psychiat. 52:34-38; 1991.
33. Rickels, K.; Wiseman, K.; Norstad, N.; Singer, M.; Stoltz, D.; Brown, A.; Danton, J. Buspirone and diazepam in anxiety: A controlled study. J. Clin. Psychiat. 43:81-86; 1982.
34. 1A partial agonists in depression: A composite analysis of buspirone in the treatment of depression. J. Clin. Psychopharmacol. 10:67S-76S; 1990.
35. 1A receptor antagonist WAY 100135: an in vivo microdialysis study. Eur. J. Pharmacol. 239:195-202; 1993.
36. 1A receptor antagonist. Eur. J. Pharmacol. 244:251-257; 1993.
37. 3 antagonists and benzodiazepines: their comparative behavioural pharmacology. John Wiley and Sons Ltd.; 1991: 365-376.
38. 1A antagonist, BMY 7378. Eur. J. Pharmacol. 176:331-340; 1990.
39. 1A receptor antagonist, SDZ 216-525, decreases 5-HT in rat hippocampus in vivo. Br. J. Pharmacol. 109:699-702; 1993.
40. 1A selective drugs on the 5-HT behavioral syndrome. Pharmacol. Biochem. Behav. 24:1513-1519; 1986.
41. 1A receptor activation in vivo. Life Sci. 56:PL 163-168; 1995.
42. 1 receptor and of catecholaminergic systems in the behavioural response to 8-OH-DPAT in the rat. Eur. J. Pharmacol. 106:271-282; 1985.
43. 1A receptors in the rat dorsal raphe nucleus. Soc. Neurosci. Abstr. 13:1649, 1987.
44. 1A subtype. Eur. J. Pharmacol. 113:463-464; 1985.
45. Wieland, S.; Fischette, C. T.; Lucki, I. Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors. Neuropharmacology 32:561-573; 1993.
46. Wieland, S.; Goodale, D.; Lucki, I. Behavioral effects of 8-OH-DPAT: studies using the Microtaxic Ventricular Injector. J. Neurosci. Methods 30:151-159; 1989.
47. 1A receptor in rat and guinea pig hippocampal membranes. Eur. J. Pharmacol. 137:293-294; 1987.
48. 1A ligand. J. Med. Chem. 37:1406-1407; 1994.